Tait addresses OECD Working Party on Biotechnology
Joyce Tait was invited to give a presentation during the thematic session on Biomedicine and Health at the recent OECD Working Party on Biotechnology (WPB) meeting held 5-6 November 2013 in Paris.
The WPB is currently developing a project on the governance of biomedicine for Alzheimer’s disease and dementia, which is rethinking value chains for biomedicine innovation and developing new mechanisms to support the development of emerging fields of science and technology that could, in particular, lead to breakthrough innovation in research for dementia.
Drawing on her extensive experience developing and understanding appropriate and adaptive governance of innovative technology, such as synthetic biology and GM crops, Tait’s presentation focused on the need to re-think value chains in the context of biomedical research, in particular for emerging technologies, such as stem cells. It highlighted the main areas that will need to be looked at in terms of responsible innovation and regulatory science and how this would relate to research in complex diseases, such as dementia, which have proved difficult to replicate using animal models. The presentation also looked at where innovative governance mechanisms would be needed to facilitate the development of novel approaches in the drug development process.